Quality of bladder cancer care in the USA

Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):619-21. doi: 10.1586/erp.11.81.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Delayed Diagnosis
  • Guideline Adherence
  • Humans
  • Practice Guidelines as Topic
  • Predictive Value of Tests
  • Quality of Health Care*
  • Survival Rate
  • Time Factors
  • Treatment Outcome
  • United States
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / mortality
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / therapy*